Login

Invests, and empowers viable blockchain entrepreneurs, startups, and communities|Yi He,Co-Founder and Head of Ventures,Binance Labs 00:10:00

Share On Facebook Share On Twitter

Co-founder and CMO at Binance.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Phoenix Global Mining: Revitalizing Empire Mine and Expanding into Cobalt and Gold
00:10:00
What methods can we employ to responsibly provide food for an expanding global populace?|Johan Westman, CEO ,AAK
00:00:00
Cogstate Limited - Brad O’Connor Chief Executive Officer, CogState Ltd
00:10:00
Ole Kristian Sivertsen Explores Solutions for Water Scarcity and Desertification in U.S. Farming | Ole Kristian Sivertsen, CEO, Desert Control AS.
00:10:00
Mike Gold on Intermedia's Strategic Growth and Market Evolution | Michael Gold, CEO, Intermedia Partners.
00:10:00
Market Volatility and Changing Recession Expectations | Jim Kotagides, President , TTG Financial Inc.
00:10:00
Tom Metzold, Co-Director of Municipal Investments at Eaton Vance Management, comments on President Obama's "America" in a single line.
00:10:00
Exploring Tanzania's Gold Frontier: A Conversation with Dr. Ray Skipper, CEO of Endany Gold Inc.
00:10:00
Global Economic Growth and Recovery Post-Pandemic: Insights from José Martinez Sangrenetti
00:10:00
Ole Kristian Jødahl, CEO of Alimak Group (ALIG), features in VD-interviews on Investor Relations.|OLE KRISTIAN JØDAHL is PRESIDENT AND CEO Alimak Group
00:10:00
Aldebaran Resources. (TSX V.ALDE) has the right to earn up to an 80% interest in the Altar copper-gold project in the Province of San Juan, Argentina from mining company Sibanye-Stillwater|John E. Black,CEO,Aldebaran Resources Inc
00:10:00
The Future of Medicine is Predictive|Stephanie Campbell,General Partner,The Artemis Fund

© 2026 Nehu